Gullans Steven R. Ph.D. 4
4 · NeuroBo Pharmaceuticals, Inc. · Filed Jan 15, 2020
Insider Transaction Report
Form 4
Gullans Steven R. Ph.D.
Director
Transactions
- Award
Non-qualified stock option (right to buy)
2020-01-13+60,000→ 60,000 totalExercise: $8.39Exp: 2030-01-12→ Common Stock (60,000 underlying)
Footnotes (1)
- [F1]The option vests in 36 equal monthly installments beginning on 2/13/2020, such that the option will be fully vested on the third anniversary of the date of grant.